QR Kod

Exploring the Potential Role of CYP2C19 Genetic Variability in Cenobamate Treatment

<b>Background:</b> Cenobamate is a novel antiseizure medication with potential interactions involving cytochrome P450 enzymes, including CYP2C19. Genetic variability in CYP2C19 may influence drug metabolism and tolerability, although its clinical relevance in cenobamate-treated patients remains uncl...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Giovanni Falcicchio, Valeria Delmonte, Teresa Francavilla, Alessandro Introna, Maria Addolorata Mariggiò, Mariella Pafundi, Mirko Perrone, Angela Vinella, Emilio Russo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI AG 2026-06-01
Seri Bilgileri:Applied Sciences
Konular:
epilepsy
cenobamate
CYP2C19
pharmacogenetics
adverse events
precision medicine
Online Erişim:https://www.mdpi.com/2076-3417/16/11/5679
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller